Pulmatrix (PULM) Price to Sales (2014 - 2024)

Pulmatrix has disclosed Price to Sales across 11 years of filings, most recently posting 8497.65 for Q4 2024.

• In Q4 2024, Price to Sales rose 275347.31% year-over-year to 8497.65; the TTM figure through Dec 2024 stood at 3.27 (up 250.85% YoY), while the FY2024 annual figure was 3.27, up 250.85% from the prior year.
• Price to Sales came in at 8497.65 for Q4 2024 at Pulmatrix, up from 21.35 in the prior quarter.
• In the past five years, Price to Sales ranged from a high of 8497.65 in Q4 2024 to a low of 1.09 in Q1 2024.
• Average Price to Sales over 5 years is 440.57, with a median of 10.52 recorded in 2020.
• Year-over-year, Price to Sales plunged 86.64% in 2022 and surged 275347.31% in 2024.
• Over 5 years, Price to Sales stood at 17.11 in 2020, then surged by 261.8% to 61.9 in 2021, then sank by 86.64% to 8.27 in 2022, then plunged by 62.68% to 3.09 in 2023, then surged by 275347.31% to 8497.65 in 2024.
• Per Business Quant data, the three most recent Price to Sales figures were 8497.65 in Q4 2024, 21.35 in Q3 2024, and 4.54 in Q2 2024.